Announcements Trials
Browse Landscape

Phase

Phase NA 36Phase 2 5Phase EARLY_PHASE1 1Phase 4 1Phase 3 1

Status

Completed 19Active not recruiting 5Unknown 2Recruiting 2

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Tumor-Agnostic 1Other 1CNS 1Breast 1

Conditions

Neoplasms 2Peripheral Nervous System Diseases 1Overweight 1Obesity 1Neuroectodermal Tumors, Primitive 1Medulloblastoma 1Infratentorial Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Bone Metabolism Biomarkers 1

Interventions

pembrolizumab 198Nivolumab 146Carboplatin 133Specimen Handling 130Magnetic Resonance Spectroscopy 116Cyclophosphamide 112Paclitaxel 106Biopsy 97Cisplatin 94Radiotherapy 89durvalumab 83Dexamethasone 80atezolizumab 73Ipilimumab 66Gemcitabine 60Doxorubicin 60Rituximab 59Lenalidomide 56Docetaxel 55olaparib 51Etoposide 51Bevacizumab 51Fluorouracil 49Capecitabine 49Radiation 47Oxaliplatin 47Radiosurgery 43Prednisone 43venetoclax 41Taxes 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Active not recruiting × Exercise × Clear all
NCT05656651 2026-05-15

ACTIVE

Universität Duisburg-Essen

Phase 2 Active not recruiting
60 enrolled
Tumor-Agnostic

Neoplasms

NCT01419730 2026-04-07

Vitamin D and Physical Activity on Bone Health

University of Rochester

Phase 2 Active not recruiting
191 enrolled

Bone Metabolism Biomarkers

NCT01878617 2025-11-13

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
660 enrolled
CNS

Brain Neoplasms, Medulloblastoma, Infratentorial Neoplasms, Neuroectodermal Tumors, Primitive

NCT04298086 2025-07-11

A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
43 enrolled
BreastOther

Breast Neoplasms, Obesity, Overweight

NCT05488873 2024-07-22

A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy

WinSanTor, Inc

Phase 2 Active not recruiting
60 enrolled

Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡